Biotechs Rev Up To Go Public, Spurring Hope For The Sector
A smattering of biotech companies have signaled plans to go public in recent days, kicking off what industry insiders expect to be a busy spring and summer for the public markets. Despite a rocky past few weeks for geopolitics, industry insiders are hopeful that 2026's initial public offering market could trigger a steady return to normalcy.
Doctors Hope Justices Maintain Shield Against Med Mal Suits
A case headed to the U.S. Supreme Court next week could roll back a legal doctrine that physicians say is key to protecting them from frivolous medical malpractice suits filed by patients who've already lost in state court.
3 Things To Know About Marine's Abortion Pill Discovery Row
A Marine pilot accused of duping a Texas woman with whom he had an intimate relationship into taking abortion pills by lacing her drink is now locked in a dogged discovery battle over the release of salacious text messages and is headed back to court Wednesday. Here, Law360 examines three things to know about the case ahead of the hearing.
Biotechs Rev Up To Go Public, Spurring Hope For The Sector
A smattering of biotech companies have signaled plans to go public in recent days, kicking off what industry insiders expect to be a busy spring and summer for the public markets. Despite a rocky past few weeks for geopolitics, industry insiders are hopeful that 2026's initial public offering market could trigger a steady return to normalcy.
Doctors Hope Justices Maintain Shield Against Med Mal Suits
A case headed to the U.S. Supreme Court next week could roll back a legal doctrine that physicians say is key to protecting them from frivolous medical malpractice suits filed by patients who've already lost in state court.
3 Things To Know About Marine's Abortion Pill Discovery Row
A Marine pilot accused of duping a Texas woman with whom he had an intimate relationship into taking abortion pills by lacing her drink is now locked in a dogged discovery battle over the release of salacious text messages and is headed back to court Wednesday. Here, Law360 examines three things to know about the case ahead of the hearing.
Expert Analysis
The outlook for rural hospitals has grown more concerning, as recent policy and regulatory developments are decrea... (more story)
Several pending cases target the issue of whether generative AI may appropriately replace human professional decis... (more story)
In this month's bid protest roundup, Brian Doll at MoFo delves into three recent decisions from the Government Acc... (more story)
Deals & Corporate Governance More
Retirement plan participants have hit hospital system Providence Health & Services with a proposed class action accusing the Washington-based nonprofit of losing nearly $70 million in assets by sticking with a... (more story)
President Donald Trump recently announced 100% tariffs on certain imported pharmaceutical products, with opportunities for drug companies to lower their tariff rates to zero, but questions remain about the req... (more story)
Venture-backed pre-clinical biotechnology firm CrossBridge Bio Inc., advised by Cooley LLP, on Tuesday announced that it has agreed to be bought by pharmaceutical giant Eli Lilly & Co. in a deal worth up to $300 million.
American Industrial Partners has agreed to acquire Avanos Medical Inc. in an all-cash transaction valued at nearly $1.3 billion, a take-private deal steered by three law firms, Avanos announced Tuesday.
The U.S. Chamber of Commerce and other business groups urged the U.S. Supreme Court to take up an appeal from Sanofi-Aventis, Eli Lilly, Novo Nordisk and AstraZeneca, arguing the Second Circuit's revival of an... (more story)
In this week's Taxation With Representation, Gilead Sciences Inc. acquires clinical-stage biotechnology company Tubulis GmbH, private equity firm Court Square Capital Partners closes a multibillion-dollar fund... (more story)
Digital Health & Technology More
A pending motion to dismiss the Michigan attorney general's drug-pricing case against multiple pharmacy benefit managers does not preclude the PBMs from handing over agreements between PBMs and pharmacies to t... (more story)
A data science platform said Friday that a former executive, who claims he was not paid after investing $750,000 into the business, cannot drag three out-of-state people loosely connected to the company into a... (more story)
Two pharmacy benefit managers can't dodge an antitrust lawsuit accusing them of price-fixing reimbursement rates because Michigan has properly claimed an antitrust violation, state Attorney General Dana Nessel... (more story)
Applied Medical Resources Corp. has urged a California federal court to reject Medtronic Inc.'s attempt to ditch its roughly $382 million antitrust trial loss, arguing that Medtronic is simply repeating "erron... (more story)
How is your work-life balance? Are you content with your compensation and opportunities for advancement at work? Take the 2026 Law360 Lawyer Satisfaction Survey and share your thoughts.
An Inova Health Care Services patient is urging a Virginia federal judge to grant final approval to a $3.1 million deal to resolve claims the healthcare system unlawfully shared private health information with... (more story)
Policy & Compliance More
A divided Pennsylvania Commonwealth Court struck down a ban on Medicaid funding for abortions, declaring Monday that the ban violates a fundamental right to reproductive autonomy under the state's constitution... (more story)
The U.S. Supreme Court on Monday declined to review the dismissal of a civil suit against former New York Gov. Andrew Cuomo and other former state officials over COVID-19-related deaths in nursing homes that a... (more story)
Biotechnology company ImmunityBio Inc.'s stock slipped by 21% after misleading statements on a podcast by the company's founder about its lead cancer drug prompted the issuance of a warning letter from the U.S... (more story)
Counsel for the family of a man who died of an opioid overdose at age 26 told a Philadelphia jury that his doctors were responsible for pushing treatment plans that allowed him to develop an opioid addiction, ... (more story)
The U.S. Supreme Court on Monday wrestled with the potential impact of reining in — or even scrapping altogether — a 100-year-old doctrine that curbs litigants' ability to go to federal court to try to overtur... (more story)
A man accused of pocketing $12 million as a part of a larger $140 million scheme to defraud public and private healthcare programs can't get out of a second trial, as the U.S. Supreme Court declined to review ... (more story)